Celebrex and Increased bronchial secretion - a phase IV clinical study of FDA data

Summary:

Increased bronchial secretion is reported as a side effect among people who take Celebrex (celecoxib), especially for people who are female, 60+ old, also take Prozac, and have Hypothyroidism.

The phase IV clinical study analyzes which people have Increased bronchial secretion when taking Celebrex. It is created by eHealthMe based on reports of 147,540 people who have side effects when taking Celebrex from the FDA, and is updated regularly.

What is Celebrex?

Celebrex has active ingredients of celecoxib. It is often used in arthritis. eHealthMe is studying from 151,105 Celebrex users. Check the latest studies of Celebrex.

What is Increased bronchial secretion?

Increased bronchial secretion is found to be associated with 376 drugs and 411 conditions by eHealthMe. Check the latest studies of Increased bronchial secretion.

On Jul, 11, 2026

147,540 people reported to have side effects when taking Celebrex.
Among them, 12 people (0.01%) have Increased bronchial secretion.

Could Celebrex cause Increased bronchial secretion?

Among these 12 people:

What is the gender of people who have Increased bronchial secretion when taking Celebrex? *

female: 58.33 %
male: 41.67 %

What is the age of people who have Increased bronchial secretion when taking Celebrex? *

What are other drugs people take besides Celebrex? *

What are other side effects people have besides Increased bronchial secretion? *

Cough: 7 people, 58.33%
Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 4 people, 33.33%
High Blood Pressure: 4 people, 33.33%
Weakness: 4 people, 33.33%
Nausea And Vomiting: 4 people, 33.33%
Depression: 4 people, 33.33%
Fever: 4 people, 33.33%
Diarrhea: 4 people, 33.33%
Drug Ineffective: 4 people, 33.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 25.00%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 25.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 25.00%
Osteoporosis (bones weak and more likely to break): 1 person, 8.33%
Non-Hodgkin's Lymphoma Refractory (refractory malignant (cancer) cells form in the lymph system): 1 person, 8.33%
Multiple Allergies (allergy to multiple agents): 1 person, 8.33%
Menopause (end of monthly cycles in women): 1 person, 8.33%
Hormone Level Abnormal: 1 person, 8.33%
Depression: 1 person, 8.33%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 8.33%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Celebrex and have Increased bronchial secretion?

- Check whether Increased bronchial secretion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Celebrex:

Celebrex (151,105 reports)

Browse all side effects of Celebrex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Increased bronchial secretion:

Increased bronchial secretion (376 drugs)

Browse all the conditions that are associated with Increased bronchial secretion:

Increased bronchial secretion (411 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on celecoxib (the active ingredients of Celebrex) and Celebrex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.